ClinicalTrials.gg
Status unknownNCT03224845COACHUpdated Aug 21, 2024

Courageous Parents, Courageous Children

An interventional study of Cognitive behavioural skills training in Anxiety Disorder, sponsored by Nova Scotia Health Authority. Status unknown at 1 site in Canada. Per ClinicalTrials.gov, last updated 2024-08-21.

Sponsored by Nova Scotia Health Authority · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2024), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Sex
All
01

Study summary

Anxiety disorders usually start in childhood and adolescence and are associated with social and occupational difficulties in adulthood. Children who have a parent with an anxiety disorder and who find new situations distressing and avoid them are at an increased risk for developing an anxiety disorder. Research suggests that anti-anxiety parenting can help children grow up courageous and calm. It is, however, difficult to parent in an anti-anxiety way when the parent has an anxiety disorder himself or herself.

This research study will test the efficacy of a new program designed to prevent the onset or persistence of anxiety disorders in children at risk for anxiety disorders. The investigators will first help parents learn skills to cope with their own anxiety and then coach them to share these skills with their children and parent in an anti-anxiety way. The goal is to intervene early enough in the children's lives so that they can be free of anxiety disorders and lead happy, healthy and productive lives in adulthood.

02

Conditions studied

  • Anxiety Disorder

Browse trials for

03

In context

Anxiety Disorders

5,065 studies on the registry are indexed under Anxiety Disorders; 1,408 are open to participants now.

This study's planned enrollment of 88 is close to the median of 80 across 4,339 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Nova Scotia Health Authority is the lead sponsor of 264 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Parents:

Inclusion criteria:

Parents will be included if they have a current diagnosis of at least one anxiety disorder, one or more children between the ages two and eight years in their own care, capacity to provide informed consent, and ability to speak English well enough to benefit from the intervention.

Exclusion criteria:

Exclusion criteria for parents are receipt of an adequate course (6 or more sessions) of structured psychological therapy in the past 12 months, or plans to move out of Nova Scotia within the next three years. We will include parents with co-morbid mood disorders. However, those whose mood disorder is the primary complaint will be referred for treatment for their mood before being re-assessed. We will exclude parents with disorders that would interfere with the standard treatment protocol delivery; these include lifetime schizophrenia, autism, intellectual disability and current drug and alcohol use disorder.

Offspring:

Inclusion criteria:

Children are eligible if they are aged two to eight and if they have a score of inhibited temperament (negative emotionality) one standard deviation or more above the mean of an age-matched normative sample on the Laboratory Assessment of Temperament.

Exclusion criteria:

Those with lifetime schizophrenia, autism, general intellectual disability, and current drug and alcohol addiction will be excluded, as these conditions would impact on the standard delivery of the parenting intervention. We will exclude children currently receiving treatment for anxiety.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
88 participants (estimated)

Study arms

  • Experimental
    Cognitive behavioural skills training

    Behavioral: Cognitive behavioural skills training

  • No intervention
    No intervention

    Participants in the control group will receive their usual clinical care and will not be discouraged from seeking any intervention.

Interventions

  • BehavioralCognitive behavioural skills training

    The intervention will be delivered in two stages: First, the parent with an anxiety disorder will attend between six and sixteen weekly sessions of cognitive behavioural skills training focusing on their own anxiety. They will work on developing behaviours that will help them become less anxious in the long-run and on learning to evaluate danger in a realistic way. Next, the parent will take part in four to eight weekly sessions of anti-anxiety parenting skills training aiming to help them transfer the skills that they learned into parenting their children. In the parenting intervention, the parents will be guided to gradually expose their children to new situations, build communication skills and confidence, in addition to general parenting skills and principles.

06

What researchers measure

Primary outcomes

  1. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of anxiety disorder in the offspring

    Time frame: One year post randomization

  2. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of anxiety disorder in the offspring

    Time frame: Two years post randomization

  3. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of anxiety disorder in the offspring

    Time frame: Three years post randomization

  4. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of anxiety disorder in the offspring

    Time frame: Five years post randomization

  5. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of anxiety disorder in the offspring

    Time frame: Seven years post randomization

  6. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of anxiety disorder in the offspring

    Time frame: Ten years post randomization

Secondary outcomes

  1. Teaching Task Battery

    Parenting behaviours

    Time frame: One year post randomization

  2. Teaching Task Battery

    Parenting behaviours

    Time frame: Two years post randomization

  3. Structured Clinical Interview for DSM-5 diagnoses (SCID-5)

    Diagnosis of anxiety disorder in the parent

    Time frame: One year post randomization

  4. Structured Clinical Interview for DSM-5 diagnoses (SCID-5)

    Diagnosis of anxiety disorder in the parent

    Time frame: Two years post randomization

  5. Laboratory Temperament Assessment Battery

    Temperament in the offspring

    Time frame: One year post randomization

  6. Laboratory Temperament Assessment Battery

    Temperament in the offspring

    Time frame: Two years post randomization

  7. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of major mood and psychotic disorders in offspring

    Time frame: Three years post randomization

  8. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of major mood and psychotic disorders in offspring

    Time frame: Five years post randomization

  9. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of major mood and psychotic disorders in offspring

    Time frame: Seven years post randomization

  10. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

    Diagnosis of major mood and psychotic disorders in offspring

    Time frame: Ten years post randomization

  11. Global Assessment of Functioning

    Functioning in the offspring

    Time frame: One year post randomization

  12. Global Assessment of Functioning

    Functioning in the offspring

    Time frame: Two years post randomization

  13. Global Assessment of Functioning

    Functioning in the offspring

    Time frame: Three years post randomization

  14. Global Assessment of Functioning

    Functioning in the offspring

    Time frame: Five years post randomization

  15. Global Assessment of Functioning

    Functioning in the offspring

    Time frame: Seven years post randomization

  16. Global Assessment of Functioning

    Functioning in the offspring

    Time frame: Ten years post randomization

  17. Screen for Child Anxiety Related Disorders

    Anxiety in the offspring - continuous

    Time frame: One year post randomization

  18. Screen for Child Anxiety Related Disorders

    Anxiety in the offspring - continuous

    Time frame: Two years post randomization

  19. Screen for Child Anxiety Related Disorders

    Anxiety in the offspring - continuous

    Time frame: Three years post randomization

  20. Screen for Child Anxiety Related Disorders

    Anxiety in the offspring - continuous

    Time frame: Five years post randomization

  21. Screen for Child Anxiety Related Disorders

    Anxiety in the offspring - continuous

    Time frame: Seven years post randomization

  22. Screen for Child Anxiety Related Disorders

    Anxiety in the offspring - continuous

    Time frame: Ten years post randomization

  23. Spence Children's Anxiety Scale

    Anxiety in the offspring - continuous

    Time frame: One year post randomization

  24. Spence Children's Anxiety Scale

    Anxiety in the offspring - continuous

    Time frame: Two years randomization

  25. Spence Children's Anxiety Scale

    Anxiety in the offspring - continuous

    Time frame: Three years post randomization

  26. Spence Children's Anxiety Scale

    Anxiety in the offspring - continuous

    Time frame: Five years post randomization

07

Study locations

1 of 1 sites recruiting
  • Nova Scotia Health
    Halifax, Nova Scotia B4E 0H4, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2017 (actual). Primary completion is estimated for Sep 2025, 96 months after the start.

Of 2,720 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 96 months is above that.

Counting every sponsor, half of 2,789 studies reached it within 12 months; a quarter within 5 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2017
First posted
Jul 21, 2017
StartActual
Sep 17, 2017
Primary completionEst.
Sep 2025
CompletionEst.
Sep 2025
Last update
Aug 21, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03224845
Responsible party
Sponsor
First posted
Jul 21, 2017
Start date
Sep 17, 2017
Primary completion
Sep 2025 (estimated)
Completion
Sep 2025 (estimated)
Last update
Aug 21, 2024

Study contacts

Barbara Pavlova, PhD DClinPsy RPsych
Contact
barbara.pavlova@dal.ca
902 473 2585
Jill Cumby, RN
Contact
jill.cumby@nshealth.ca
902 473 1781

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion